The Electronic Retailing Self-Regulation Program (ERSP), an investigative unit of the advertising industry’s system of self-regulation, has reportedly determined that clinical testing provides a reasonable basis for Farr Laboratories, LLC to make general performance claims in online ads for Prosta-Q, a dietary supplement. According to ERSP, the company can continue to claim that its product provides relief from the symptoms associated with chronic prostatitis and general pelvic pain, although it recommended that Farr Labs modify the claim that the product’s ingredients "have been clinically proven to aid digestion." A banner ad asserting that the product is the "#1 doctor supported and recommended prostate supplement" was apparently disseminated by a third-party affiliate advertiser, and the company informed ERSP that it had requested that the advertiser stop running the banner.